Investigations for bone metastasis from an unknown primary

Area of Science:

• Oncology
• Diagnostic Imaging
• Pathology

Background:

• Identifying the primary tumor site in patients with bone metastases is crucial for effective treatment planning.
• A variety of diagnostic investigations are employed, but their respective contributions are not always clear.
• This study evaluates the diagnostic utility of different investigations in a cohort of patients with unknown primary tumors presenting with bone metastases.

Purpose of the Study:

• To assess the diagnostic yield of various investigations in identifying the primary tumor in patients with bone metastases.
• To compare the effectiveness of radionuclide bone scanning, radiography, ultrasound, CT, and tumor markers.
• To determine the role of bone biopsies in the diagnostic workup.

Main Methods:

• Retrospective analysis of 152 patients with bone metastases and no known primary tumor.
• Evaluated investigations included bone scan, chest radiograph, abdominal ultrasound, CT scans (chest, abdomen, brain), and tumor marker assays.
• Final diagnosis served as the reference standard; bone biopsy findings were analyzed based on location and histology.

Main Results:

• Lung (37), prostate (26), and breast/female genital tract (24) were the most common primary sites.
• Bone biopsies, particularly those performed by rheumatologists, frequently identified the primary tumor or its histological type (adenocarcinoma, epidermoid carcinoma).
• Tumor marker assays were generally of limited value, with prostate-specific antigen being a notable exception.

Conclusions:

• Bone biopsies are a key investigation for determining the primary tumor site or histological type in patients with bone metastases.
• Rheumatologist-performed bone biopsies, often under fluoroscopic guidance, provide significant diagnostic information.
• While tumor markers can be positive, their utility in pinpointing the primary tumor origin is limited.